Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

FDA Opens Early Access to Novel Pancreatic Cancer Drug Generating Buzz

FDA Opens Early Access to Novel Pancreatic Cancer Drug Generating Buzz
ShareXFacebook

(MedPage Today) -- The FDA has given the green light to an expanded access program (EAP) for the investigational pancreatic cancer drug daraxonrasib. In a "safe to proceed" letter to Revolution Medicines, the FDA gave its approval to initiate...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement